Design of New Oxazaphosphorine Anticancer Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|9|963-978

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.9, 2007-03, pp. : 963-978

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Cysteine Residues of Biomolecules: New Approaches for the Design of Antiviral and Anticancer Drugs

By  

Current Medicinal Chemistry, Vol. 9, Iss. 12, 2002-06 ,pp. : 1167-1185

Bentham Science Publishers

Access to resources Recommend Favorite

Using Insights into Pim1 Structure to Design New Anticancer Drugs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. : 3964-3978

Bentham Science Publishers

Access to resources Recommend Favorite

Safety profile of new anticancer drugs

By Mansi Laura   Thiery-Vuillemin Antoine   Nguyen Thierry   Bazan Fernando   Calcagno Fabien   Rocquain Julien   Demarchi Martin   Villanueva Cristian   Maurina Tristan   Pivot Xavier  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 301-317

Informa Healthcare

Access to resources Recommend Favorite

The Prodigiosins: A New Family of Anticancer Drugs

By  

Current Cancer Drug Targets, Vol. 3, Iss. 1, 2003-02 ,pp. : 57-65

Bentham Science Publishers

Access to resources Recommend Favorite

Platinum Group Antitumor Chemistry: Design and development of New Anticancer Drugs Complementary to Cisplatin

By  

Current Medicinal Chemistry, Vol. 13, Iss. 11, 2006-05 ,pp. : 1337-1357

Bentham Science Publishers

Access to resources Recommend Favorite